Allosteric activation, including substrate activation, of P450 enzymes has been extensively documented[1719]
Lets see where it leads
In developing regions, this financial barrier is even more pronounced, slowing market penetration despite growing obesity prevalence While efforts are underway to improve affordabilityincluding the introduction of generic formulations and price negotiations in certain marketsthe perception of GLP-1 therapies as premium, high-cost treatments can deter both patients and providers from widespread adoption Overcoming these challenges through the development of cost-effective alternatives, enhanced insurance support, and patient assistance programs will be vital for ensuring sustained and inclusive market growth in the GLP-1 receptor agonists obesity drugs market GLP-1 Receptor Agonists Obesity Drugs Market Scope The market is segmented on the basis of drug type, route of administration, application, and distribution channel
Food supplement: Do not exceed the recommended daily dose
Numerous studies have investigated its role in antioxidant defense, detoxification, immune function, and other aspects of health
10.1016/j.plantsci.2006.04.009 4 AnjumN